NCT06050343View on ClinicalTrials.gov

Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

May 4, 2018

Study Completion Date

May 4, 2018

Conditions
BioequivalenceTherapeutic Equivalency
Interventions
DRUG

Humulin® Regular

subcutaneous injection at a dose of 0.3 IU / kg

DRUG

Rinsulin® R

subcutaneous injection at a dose of 0.3 IU / kg

Trial Locations (1)

117036

"National Medical Research Center of Endocrinology of the Ministry of Health of the Russian Federation", Moscow

Sponsors

Lead Sponsor

Geropharm
All Listed Sponsors
lead

Geropharm

INDUSTRY